相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
Shihui Chen et al.
DIGESTIVE AND LIVER DISEASE (2015)
Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
Veronique S. Chachay et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Resveratrol modulates autophagy and NF-kappa B activity in a murine model for treating non-alcoholic fatty liver disease
Lake Li et al.
FOOD AND CHEMICAL TOXICOLOGY (2014)
Caffeine Stimulates Hepatic Lipid Metabolism by the Autophagy-Lysosomal Pathway in Mice
Rohit A. Sinha et al.
HEPATOLOGY (2014)
Chemistry, Stability and Bioavailability of Resveratrol
Antonio Francioso et al.
MEDICINAL CHEMISTRY (2014)
Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
Forouzan Faghihzadeh et al.
NUTRITION RESEARCH (2014)
Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease
Sara Heeboll et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Resveratrol Exacerbates Both Autoimmune and Viral Models of Multiple Sclerosis
Fumitaka Sato et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Resveratrol attenuates vascular endothelial inflammation by inducing autophagy through the cAMP signaling pathway
Ming-liang Chen et al.
AUTOPHAGY (2013)
Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway
Hai Yan Quan et al.
BIOCHEMICAL PHARMACOLOGY (2013)
p73 regulates autophagy and hepatocellular lipid metabolism through a transcriptional activation of the ATG5 gene
Z. He et al.
CELL DEATH AND DIFFERENTIATION (2013)
Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats
Peng Xin et al.
FOOD AND CHEMICAL TOXICOLOGY (2013)
Nonalcoholic fatty liver disease: Current and potential therapies
Mohamed Abdellah Ibrahim et al.
LIFE SCIENCES (2013)
Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet
Goiuri Alberdi et al.
NUTRITION (2013)
Sulfate Metabolites Provide an Intracellular Pool for Resveratrol Generation and Induce Autophagy with Senescence
Ketan R. Patel et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Finding a Target for Resveratrol
Ruth I. Tennen et al.
CELL (2012)
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Sung-Jun Park et al.
CELL (2012)
Phenotyping the effect of diet on non-alcoholic fatty liver disease
Nicole J. W. de Wit et al.
JOURNAL OF HEPATOLOGY (2012)
Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and Feedbacks
Sebastian Alers et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
SREBPs: metabolic integrators in physiology and metabolism
Tae-Il Jeon et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
The Role of Diet and Nutrient Composition in Nonalcoholic Fatty Liver Disease
Erin Marie McCarthy et al.
JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS (2012)
AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
Yu Li et al.
CELL METABOLISM (2011)
Functions of Autophagy in Hepatic and Pancreatic Physiology and Disease
Mark J. Czaja
GASTROENTEROLOGY (2011)
The cAMP/PKA Pathway Rapidly Activates SIRT1 to Promote Fatty Acid Oxidation Independently of Changes in NAD+
Zachary Gerhart-Hines et al.
MOLECULAR CELL (2011)
SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
Yasar Colak et al.
MEDICAL SCIENCE MONITOR (2011)
Distinct Effects of Calorie Restriction and Resveratrol on Diet-Induced Obesity and Fatty Liver Formation
Eveliina Tauriainen et al.
JOURNAL OF NUTRITION AND METABOLISM (2011)
AMPK in cardiovascular health and disease
Najeeb A. Shirwany et al.
ACTA PHARMACOLOGICA SINICA (2010)
Methods in Mammalian Autophagy Research
Noboru Mizushima et al.
CELL (2010)
Dengue Virus-Induced Autophagy Regulates Lipid Metabolism
Nicholas S. Heaton et al.
CELL HOST & MICROBE (2010)
Autophagy: A Potential Link between Obesity and Insulin Resistance
Patrice Codogno et al.
CELL METABOLISM (2010)
SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1
Michelle Pacholec et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Trans- but Not Cis-Resveratrol Impairs Angiotensin-II-Mediated Vascular Inflammation through Inhibition of NF-κB Activation and Peroxisome Proliferator-Activated Receptor-γ Upregulation
Cristina Rius et al.
JOURNAL OF IMMUNOLOGY (2010)
Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy
E. Morselli et al.
CELL DEATH & DISEASE (2010)
Resveratrol: Its Biologic Targets and Functional Activity
Shazib Pervaiz et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway
Guang-Li Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats
Leonor Rivera et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Hepatic Autophagy Is Suppressed in the Presence of Insulin Resistance and Hyperinsulinemia INHIBITION OF FoxO1-DEPENDENT EXPRESSION OF KEY AUTOPHAGY GENES BY INSULIN
Hui-Yu Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
CELL BIOLOGY Another way to get rid of fat
Rudolf Zechner et al.
NATURE (2009)
Autophagy regulates lipid metabolism
Rajat Singh et al.
NATURE (2009)
Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase
Jing Shang et al.
ACTA PHARMACOLOGICA SINICA (2008)
Resveratrol inhibits nonalcoholic fatty liver disease in rats
Luis Bujanda et al.
BMC GASTROENTEROLOGY (2008)
A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy
In Hye Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Sirt1 protects against high-fat diet-induced metabolic damage
Paul T. Pfluger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The expression of SIRT1 in nonalcoholic fatty liver disease induced by high-fat diet in rats
Xiang-Qun Deng et al.
LIVER INTERNATIONAL (2007)
Resveratrol improves health and survival of mice on a high-calorie diet
Joseph A. Baur et al.
NATURE (2006)
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
GC Farrell et al.
HEPATOLOGY (2006)
Resveratrol-induced autophagocytosis in ovarian cancer cells
AW Opipari et al.
CANCER RESEARCH (2004)
Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis in 3T3-L1 adipocytes
W Yin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
KT Howitz et al.
NATURE (2003)
Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey
ES Ford et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo
SP Collins et al.
BIOCHEMICAL JOURNAL (2000)